mci-196 has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inagaki, K; Itoh, M; Kanayama, H; Katada, N; Kato, T; Sawai, Y | 1 |
| Arita, E; Auwerx, J; Horai, Y; Houten, SM; Itoh, H; Kaneko-Iwasaki, N; Mataki, C; Morimoto, K; Murahashi, K; Sato, H; Schoonjans, K; Sugizaki, T; Suzuki, T; Watanabe, M | 1 |
1 trial(s) available for mci-196 and Metabolic Syndrome
| Article | Year |
|---|---|
Comparison of efficacy of pitavastatin and colestimide in Japanese patients with diabetes mellitus complicated by hyperlipidemia and metabolic syndrome.
Topics: Adult; Aged; Albuminuria; Atherosclerosis; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Diabetes Complications; Epichlorohydrin; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Imidazoles; Insulin Resistance; Japan; Male; Metabolic Syndrome; Middle Aged; Obesity; Quinolines; Resins, Synthetic; Triglycerides; Weight Loss | 2011 |
1 other study(ies) available for mci-196 and Metabolic Syndrome
| Article | Year |
|---|---|
Bile acid binding resin improves metabolic control through the induction of energy expenditure.
Topics: Animals; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Energy Metabolism; Epichlorohydrin; Glucose; Glucose Tolerance Test; Imidazoles; Insulin Resistance; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Protein Binding; Receptors, G-Protein-Coupled; Resins, Synthetic; Signal Transduction | 2012 |